All In Biotech

Drug Trial Radar · NCT05865431

Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light

Last checked: Nov 19, 2026Latest source record: Apr 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

17

Actual

Start

Mar 17, 2017

Primary completion

Feb 2, 2018

Study completion Feb 2, 2018

Sponsor

Lead sponsor
University of California, DavisAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is quantification of singlet oxygen species in the skin after exposure to Ultraviolet A (UVA) light

Conditions

  • Sun Damaged Skin

Interventions

  • Zinc Oxide and AvobenzoneDrug

    Zinc Oxide is applied to one area of the forearm, Avobenzone is applied to another area of the forearm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Amount of singlet oxygen generated by the left forearm skin (2 cm^2) after exposure to UVA radiation dose of 0.33 J/cm2Time frame: 5 minutes at first visit
  2. Amount of singlet oxygen generated by the left forearm skin (2 cm^2) after exposure to UVA radiation dose of 8.25 J/cm2Time frame: 5 minutes at first visit
  3. Amount of singlet oxygen generated by the left forearm skin (2 cm^2) after exposure to UVA radiation dose of 16.5 J/cm2Time frame: 5 minutes at first visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of California, Davis

    Sacramento, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.